| 
April 18, 2023
Yesterday at a glance: the kidney dialysis specialist hovered around the $22.63 level after closing Friday at $23.26 and shedding 2.71%, as it reached reached yesterday's session close.
United States Building Permits (Mar) is next today at 12:30 UTC.
Meanwhile, United States TIC Net Long-Term Transactions (Feb) came out at 71 billion, while a consensus of analysts was expecting 101.9 billion. United States NY Empire State Manufacturing Index (Apr) released yesterday at 12:30 UTC with a figure of 10.8, while the previous figure was -24.6.
Technical analysis shows that Fresenius Medical Care AG & Co. KGaA could begin to recover as it approaches significant support, now 12 cents away from $22.51. Dipping below could be an indication that further losses are ahead.
Fresenius Medical Care was not the only decliner in the health care sector; UnitedHealth went down to $505.35, losing 1.26% after it closed at $511.79 yesterday.
On the other hand, positive performances could be seen by looking at other health care stocks as Medtronic added 1.75% to its value, and traded at $82.12. Novo Nordisk traded at $171.07 after closing yesterday's trading day at $168.6 (up 1.47%).
With markets struggling for positive sentiment, upcoming macro data could potentially attract buyers in the market as tomorrow at 14:30 UTC data for United States Crude Oil Inventories will be released, with an expected decline to -2.46 million from the preceding figure of 597,000.
Furthermore, United States Building Permits (Mar) scheduled to come out today at 12:30 UTC.
The stock has been trending positively for about a month. The US-German healthcare company has managed to gain 38.95% so far this year despite trading at lows around $12.81 previously.
